[The Clinical Value of Neutrophil CD64 Index in Hematological Malignancies with Pulmonary Infection] [0.03%]
血液系统恶性肿瘤肺部感染患者中性粒细胞CD64指数的临床价值
Yin Xu,Wei-Min Dong,Yan Lin et al.
Yin Xu et al.
Objective: To investigate the clinical value of neutrophil CD64 index in hematological malignancies with pulmonary infection. Methods: ...
[Clinical Observation of Neutropenia Patients with Hematonosis Treated with Polymyxin B Sulfate] [0.03%]
聚凝胺治疗血小板减少性中性粒细胞减少症临床观察
Shun-Quan Wu,Rong Zhan
Shun-Quan Wu
Objective: To observe the clinical efficacy and safety of polymyxin B sulfate in febrile neutropenia patients with hematonosis. Methods: ...
[Transcriptional Modification and Potential Intracellular Signaling Mechanisms in Human Macrophages Primed by Interferon-γ] [0.03%]
干扰素-γ诱导的人巨噬细胞程序化活化的转录组修饰及其可能的胞内信号机制
Bei Liu,Hong-Hao Gao,Li Cheng et al.
Bei Liu et al.
Objective: To explore the transcriptional gene expression profile up-regulated in human macrophages stimulated by interferon-γ (IFN-γ) and the underlying intracellular signaling mechanisms. ...
[The Clinical Observation with Ruxolitinib as Graft-Versus-Host Disease Prophylaxis for Children with Thalassemia after Unrelated or Haploidentical Allo-Hematopoietic Stem Cell Transplantation] [0.03%]
芦可替尼作为预防无关供者或单倍型相合外周血造血干细胞移植后地中海贫血患儿移植物抗宿主病的临床观察
Ya-Mei Chen,Xiu-Li Hong,Jin-Zong Lin et al.
Ya-Mei Chen et al.
Objective: To retrospectively analyze the efficacy and safety of ruxolitinib therapy for children with thalassemia after unrelated or haploidentical stem cell transplantation. ...
[Clinical Outcomes and Prognostic Factors of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia] [0.03%]
allo-HSCT治疗难治/复发急性髓系白血病的临床疗效及预后因素分析
Dian Lou,Li Liu,Xue-Qian Yan et al.
Dian Lou et al.
Objective: To investigate the clinical outcomes and prognostic factors of refractory/relapsed acute myeloid leukemia (AML) patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT). ...
[A Sero-epidemiological Study on Transfusion-Transmissible Infectious among Volunteer Blood Donors From 2016 to 2020 in Nanjing] [0.03%]
2016至2020年南京市无偿献血者输血传播感染性疾病血清流行病学调查分析
Tao Feng,Rui Zhu,Chun Zhou et al.
Tao Feng et al.
Objective: To investigate the status of transfusion-transmissible infection (TTI) among voluntary blood donors in Nanjing in recent five years, in order to provide data support for the recruitment of blood donors and form...
[Factors Influencing the efficacy of Plasma Exchange in the Treatment of Immune Thrombocytopenic Purpura] [0.03%]
影响血浆置换治疗免疫性血小板减少症疗效的因素分析
Xiao-Wen Gu,Jian-Guo You
Xiao-Wen Gu
Objective: To observe the efficacy of plasma exchange in the treatment of patients with immune thrombocytopenic purpura (ITP), and to analyze the factors influencing the efficacy of plasma exchange in the treatment of ITP...
[Serological Characteristics and Molecular Biological Mechanism of AEL.02 Subtype] [0.03%]
[AEL.02亚型血清学特性及分子生物学机制]
Feng-Wu Qiu,Xiao-Ling Shi,Mei-Hua Li et al.
Feng-Wu Qiu et al.
Objective: To explore the serological characteristics and molecular biological mechanism of an ael subtype specimen. Methods: The ABO b...
[Study on BW.12 Subtype Caused by c.278C>T Mutation in Exon 6 of ABO Gene] [0.03%]
ABO基因外显子6c.278C＞T突变所致Bw12亚型的研究
Xin Liu,Lian-Hui Wang,Xiu-Yun Xu et al.
Xin Liu et al.
Objective: To investigate the effect of ABO gene α-1,3-D galactosyl transferase mutation on B antigen expression and its molecular mechanism. Methods: ...
[Study on the Therapeutic Effect of Lenalidomide on Hemophilic Arthropathy] [0.03%]
来那度胺治疗血友病关节炎疗效的探索性研究
Ye-Fan Wang,Zhen-Yang Lin,Fei-Xu Zhang et al.
Ye-Fan Wang et al.
Objective: To explore the effect of lenalidomide on human fibroblast-like synovial cells (HFLS) and the therapeutic efficacy on hemophilic arthropathy in hemophilia A mice model. ...